GSK announces new drug applications accepted for review in China, Japan
GSK (GSK) announced that new drug applications have been accepted for review by the China National Medical Products Administration and ...
The Economist22h
The bad side-effects of China’s campaign to cut drug costs
These are some of the problems that doctors have encountered in China’s public hospitals. They have been speaking out in recent weeks, questioning the quality of the country’s drugs and urging reform ...
In China, Rare Dissent Over a Program to Save on Drug Costs
Top doctors raised concerns about domestically made drugs, saying Beijing’s effort to lower costs is sacrificing quality.
In China, Government Data on Drugs Blocked From Public After Backlash
Criticism over how the Chinese government buys drugs for its public health care system has ignited frustration over the ...
Vyluma Announces Acceptance of Drug Application for NVK002 by China’s National Medical Products Administration (NMPA)
With its acceptance by the NMPA, NVK002 is now under regulatory review across three major global markets: the United States, the European Union, and China. This milestone reinforces Vyluma’s vision of ...
PharmiWeb3d
Depemokimab applications accepted for review in China and Japan for asthma with type 2 inflammation and CRSwNP
today announced that new drug applications have been accepted for review by the China National Medical Products Administration and submitted to the Japanese Ministry of Health, Labour and Welfare for ...
Yahoo Finance14d
Zai Lab Announces Acceptance of New Drug Application for KarXT for the Treatment of Schizophrenia
January 17, 2025--(BUSINESS WIRE)--Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) today announced that China’s National Medical Products Administration (NMPA) has accepted the New Drug Application ...
pharmaphorum1y
China is third country to approve Alzheimer’s drug Leqembi
Eisai has said it will distribute the new drug in China using a specialised medical representative force, coupled with an awareness-raising campaign that aims to encourage diagnosis of Alzheimer ...
Cure Today27d
FDA Accepts New Drug Application For Taletrectinib in ROS1+ NSCLC
The Food and Drug Administration (FDA) has accepted a new drug application (NDA) with priority review for ... which was conducted in China, as well as the TRUST-II global study, both of which ...